Etienne G, Dulucq S, Nicolini F-E, Morisset S, Fort M-P, Schmitt A, Etienne M, Hayette S, Lippert E, Bureau C, Tigaud I, Adiko D, Marit G, Reiffers J, Mahon F-X. Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy. Haematologica [Internet]. 2014Mar.5 [cited 2026Nov.12];99(3):458-64. Available from: https://haematologica.org/article/view/6961